Who founded Catabasis Pharmaceuticals?

Catabasis Pharmaceuticals was founded by Jill C. Milne.

Who are Catabasis Pharmaceuticals's investors?

Catabasis Pharmaceuticals's investors include Clarus Ventures, Lightstone Ventures.

How much funding has Catabasis Pharmaceuticals raised?

Catabasis Pharmaceuticals has disclosed $298.2M raised across 3 rounds.

Where is Catabasis Pharmaceuticals headquartered?

Catabasis Pharmaceuticals is headquartered in Cambridge, US.

Catabasis Pharmaceuticals

Cambridge, US · Delaware corporation · 2 known investors

Find your way into Catabasis Pharmaceuticals

2 people in our graph share verified history with the Catabasis Pharmaceuticals team — schools, employers, funds. One of them is your warm intro.

Jonathan Violinunlockedknows Ian Sanderson · together at Catabasis Pharmaceuticals

knows the team · via Catabasis Pharmaceuticals

Biotech

Founders & leadership

Jill C. MilneCo-Founder, President, & CEO2021–2026

Ian Sanderson ExecutiveExecutive Officer at Catabasis Pharmaceuticals.

Board

Ron LauferBoard director

Nicholas Galakatos Board directorGeneral Partner at Clarus Defined Exit

Jean GeorgeBoard directorManaging Partner at Lightstone Ventures

Michael RossBoard director

Kenneth BateBoard director

Investors · 2

Clarus VenturesinferredMenlo Park

How we know: board seat on SEC Form D · Not right? Tell us

Lightstone VenturesreportedPortola Valley

How we know: funding news · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$298.2M disclosed across 3 rounds · 2015–2021

▶$175.7MraisedFeb 2021 · 6 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

Kenneth BateDirector
Joanne T. BeckDirector
Hugh ColeDirector
Gregg LapointeDirector
Jonathan ViolinDirector
Fred CalloriDirector
Noah ClauserExecutive Officer
Ben HarshbargerExecutive Officer
Michael D. KishbauchDirector
Andrew KomjathyExecutive Officer
Andrew NicholsExecutive Officer
Jill C. MilneExecutive Officer, Director
Joanne DonovanExecutive Officer

Offering amount: $175.7M
Amount sold: $175.7M
First sale: Jan 2021
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$110MraisedFeb 2021 · 23 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

Jill C. MilneExecutive Officer, Director
Joanne DonovanExecutive Officer
Andrew NicholsExecutive Officer
Andrew KomjathyExecutive Officer
Michael D. KishbauchDirector
Kenneth BateDirector
Joanne T. BeckDirector
Hugh ColeDirector
Gregg LapointeDirector
Jonathan ViolinDirector
Fred CalloriDirector
Noah ClauserExecutive Officer
Ben HarshbargerExecutive Officer

Offering amount: $110M
Amount sold: $110M
Sales commissions: $5.5M
Placement agents: Jefferies LLC
First sale: Feb 2021
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$12.4MraisedMar 2015 · 20 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

Ron LauferDirector
Nicholas GalakatosDirector
Kenneth BateDirector
Jill C. MilneExecutive Officer, Director
Jean GeorgeDirector
Michael RossDirector
Ian SandersonExecutive Officer

Offering amount: $20.4M
Amount sold: $12.4M
First sale: Mar 2015
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who founded Catabasis Pharmaceuticals?: Catabasis Pharmaceuticals was founded by Jill C. Milne.
Who are Catabasis Pharmaceuticals's investors?: Catabasis Pharmaceuticals's investors include Clarus Ventures, Lightstone Ventures.
How much funding has Catabasis Pharmaceuticals raised?: Catabasis Pharmaceuticals has disclosed $298.2M raised across 3 rounds.
Where is Catabasis Pharmaceuticals headquartered?: Catabasis Pharmaceuticals is headquartered in Cambridge, US.